Real Options Based Analysis of Optimal Pharmaceutical Research and Development Portfolios

Explore this paper's citation graph

Summary

A method is developed to model new product development as a series of continuation/abandonment options, deciding at each stage in pharmaceutical R&D whether to proceed further or stop development, and a proposed framework provides a road map for future decisions.

Type
article
Published
2002-11-14
Cited by
121
References
36

Keywords

Portfolio, Abandonment (legal), Stochastic programming, Time horizon, New product development

References

Cited by

Related papers